|
Market Closed -
Other stock markets
|
After hours 19:38:59 | |||
| 38.30 USD | +0.98% |
|
37.40 | -2.36% |
| 06-18 | Barclays Initiates Indivior at Overweight With $46 Price Target | MT |
| 06-10 | Indivior Pharmaceuticals Insider Sold Shares Worth $1,357,200, According to a Recent SEC Filing | MT |
| Market Cap | 4.67B 4.07B 3.75B 3.53B 6.6B 440B 6.65B 44.62B 17.33B 217B 17.53B 17.15B 752B | P/E 2026 * |
12.1x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.72B 4.12B 3.79B 3.57B 6.68B 445B 6.72B 45.14B 17.53B 219B 17.73B 17.35B 760B | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 3.31x |
| Free-Float |
94.92% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | +0.98% | ||
| 1 week | +0.45% | ||
| Current month | +6.33% | ||
| 1 month | +4.82% | ||
| 3 months | +25.45% | ||
| 6 months | +7.77% | ||
| Current year | +6.74% |
| 1 week | 37.71 |  | 39.04 |
| 1 month | 32.41 | | 39.04 |
| Current year | 27.68 | | 41 |
| 1 year | 13.45 | | 41 |
| 3 years | 7.33 | | 41 |
| 5 years | 7.33 | | 41 |
| 10 years | 1.75 | | 41 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 06-07 | Sell | Chief Financial Officer | -36,000 | 0.0295% | ||
| 05-12 | Free | Chairman | 10,430 | 0.0086% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | +0.45% | +175.54% | +68.87% | 4.62B | |
| -1.21% | -5.37% | +39.94% | +145.38% | 992B | |
| -2.48% | -4.17% | +51.52% | +39.07% | 564B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 391B | |
| -1.18% | +0.25% | +25.86% | +16.53% | 330B | |
| -2.36% | -3.12% | +24.71% | +11.59% | 280B | |
| -2.45% | -2.88% | +24.29% | +30.06% | 279B | |
| -1.91% | -0.87% | -41.95% | -49.25% | 196B | |
| -1.19% | -4.65% | +16.56% | +47.00% | 184B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 156B | |
| Average | -1.53% | -1.74% | +34.78% | +42.23% | 337.58B | |
| Weighted average by Cap. | -1.77% | -2.88% | +28.23% | +63.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.1B 1.01B 950M 1.78B 119B 1.79B 12.02B 4.67B 58.42B 4.72B 4.62B 202B | 1.29B 1.12B 1.03B 973M 1.82B 121B 1.83B 12.3B 4.78B 59.79B 4.83B 4.73B 207B |
| Net income | 414M 361M 333M 313M 586M 39.06B 590M 3.96B 1.54B 19.25B 1.56B 1.52B 66.72B | 455M 396M 365M 344M 643M 42.87B 647M 4.35B 1.69B 21.13B 1.71B 1.67B 73.23B |
| Net Debt | 54.5M 47.49M 43.77M 41.17M 77.03M 5.14B 77.57M 521M 202M 2.53B 205M 200M 8.77B | -403M -351M -324M -305M -570M -38.02B -574M -3.85B -1.5B -18.74B -1.51B -1.48B -64.94B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 38.30 $ | +0.98% | 4,276,207 |
| 26-06-17 | 37.93 $ | -0.21% | 1,485,122 |
| 26-06-16 | 38.01 $ | -1.02% | 1,256,102 |
| 26-06-15 | 38.40 $ | -0.21% | 1,145,262 |
| 26-06-12 | 38.48 $ | +0.92% | 627,573 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
